Ausbiz Capital is now SureStone Capital. Same team, same ABN and AFS authorisations.

ASX: PMEPro Medicus LimitedHealth Care

Pro Medicus Signs 10-Year A$128M NYC Health + Hospitals Deal

Pro Medicus subsidiary Visage Imaging has signed a 10-year, A$128M contract to roll out its cloud-based Visage 7 platform across NYC Health + Hospitals.

By Digifin Pty Ltd · About this coverage

Key Points

  • Full Stack contract covers Visage 7 Viewer, Visage 7 Workflow and Visage 7 Open Archive
  • Platform to be implemented in the cloud on a transactional licensing model
  • Visage to migrate legacy PACS archives to Visage 7 Open Archive
  • Go-live targeted for late Q3 in the 2027 calendar year
Pro Medicus Limited (ASX:PME)

About Pro Medicus (ASX:PME)

Pro Medicus Limited is an ASX-listed healthcare imaging software company headquartered in Melbourne. It develops and licenses medical imaging software, including the Visage 7 enterprise imaging platform sold through its United States subsidiary Visage Imaging, alongside radiology information system products. Its customers are hospitals, academic medical centres and diagnostic imaging providers, principally in the United States, with further operations in Australia and Europe.

Pro Medicus (ASX:PME) released this to disclose a new 10-year contract that will put its cloud-based Visage 7 platform across NYC Health + Hospitals.

The company's wholly-owned U.S. subsidiary, Visage Imaging, Inc., has signed a 10-year, A$128M contract with NYC Health + Hospitals. The contract is for Full Stack, covering Visage 7 Viewer, Visage 7 Workflow and Visage 7 Open Archive, and is based on a transactional licensing model, which the company describes as having potential upside. Visage will complete migration from NYC Health + Hospitals legacy PACS archives to Visage 7 Open Archive, and Visage 7 will also provide enterprise distribution of images integrated to the customer's electronic health record (EHR). Planning for the rollout is to commence immediately, with go-live targeted for late Q3 in the 2027 calendar year.

The release does not explain how the A$128M figure was derived under a transaction-based model, how revenue is expected to be phased over the 10 years, or what implementation costs are involved.

Back to all ASX Company News

Source: Pro Medicus Limited (ASX:PME), 20 November 2026. Summary content supplied by Digifin Pty Ltd.

News summary only, not financial advice. It does not consider your objectives, financial situation or needs.

Friday, 20 November 2026

Also summarised today

All ASX Company News
ASX: ASGConsumer Discretionary

Autosports Group Sees H1 FY27 Revenue In Line With Plan

Autosports Group expects H1 FY27 revenue of $1.7 billion to $1.75 billion, with inventory cuts weighing on gross margin before an expected H2 margin uplift.

20 Nov, 8:26 am AEDT
ASX: DURIndustrials

Duratec Wins Santos, Home Affairs and Defence Fuel Contracts

Duratec has won three contracts worth over $200m combined, led by a four-year Santos maintenance deal, plus Yongah Hill and RAAF Base Learmonth fuel works.

20 Nov, 8:21 am AEDT
ASX: EBRHealth Care

CMS Proposes National Medicare Coverage for EBR WiSE System

CMS has proposed national Medicare coverage for EBR Systems' WiSE System under Coverage with Evidence Development, with a final decision due by February 2027.

20 Nov, 8:50 am AEDT
ASX: KOAConsumer Discretionary

Koala Written Sales Up 35.0% in First 17 Weeks of FY27

The Koala Company says written sales grew 35.0% in constant currency in the 17 weeks to 31 October, with all markets in growth, before its peak trading period.

20 Nov, 9:04 am AEDT
ASX: MC2Materials

Marimaca Reports 102m of 1.00% Cu at Pampa Medina

Marimaca Copper reported Pampa Medina assays including 102m of 1.00% Cu and 5.1g/t Ag in SPRD-21 as central zone drilling nears completion in northern Chile.

20 Nov, 8:37 am AEDT
ASX: MVFHealth Care

Monash IVF Sees FY27 Underlying NPAT Materially Below FY26

Monash IVF expects underlying FY27 NPAT to be materially below FY26 and consensus after the Australian stimulated-cycle market contracted 3.2% in Q1 FY27.

20 Nov, 9:23 am AEDT
ASX: NXTInformation Technology

NEXTDC Upgrades FY27 Revenue and Underlying EBITDA Guidance

NEXTDC raised FY27 guidance to net revenue of A$485m to A$500m and Underlying EBITDA of A$260m to A$275m, and reaffirmed capex of A$4,500m to A$5,000m.

20 Nov, 8:24 am AEDT
ASX: ORNMaterials

Orion Receives US$6.7M First Glencore Prepayment Drawdown

Orion Minerals has received a US$6.7 million first drawdown under its Glencore prepayment, allowing early works at the Prieska Copper Zinc Mine Uppers Mine.

20 Nov, 9:04 am AEDT
ASX: SGMMaterials

Sims Lifts 1H FY27 Lifecycle Services EBIT Guidance

Sims expects 1H FY27 Group Underlying EBIT of $270 million to $285 million after lifting Sims Lifecycle Services guidance to $120 million to $130 million.

20 Nov, 8:19 am AEDT

Announcement summaries are published each trading day. General advice only.

Copyright © 2026 SureStone Capital